top of page
press releases


Syndex Bio Unveils mcPCR Technology at AGBT 2026 Following $15.5M Seed Financing
mcPCR enables precise copying of DNA methylation during DNA amplification, overcoming a fundamental limitation of PCR, and unlocks new opportunities for sensitive detection of cancer, chronic disease, and in basic research Launch follows successful close of oversubscribed $15.5 million seed financing led by ARCH Venture Partners Gautam Kollu, former CCO of Grail, joins Board Syndex Bio to showcase data at AGBT in Orlando, FL from 23–26 February Cambridge, UK, 23 February 2026
Feb 23


Astoriom Acquires Precision Stability Storage
Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development Rochdale, UK, and North Carolina, US, 27 January 2026: Astoriom, a global leader in scientific research and consumer product sample stability and biorepository storage, has expanded its sample management capabilities in the US with the acquisition of Precis
Jan 27


ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026
Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy Cambridge, UK, 20 January 2026: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the keynote speakers for Cell and Gene Therapy 2026. Drs Stephen Ward (Cell and Gene Therapy Catapult) and Annarita Miccio (Imagine Institute) will lead
Jan 20
bottom of page